Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer.

Jeon EK, Won HS, Ko YH, Lee IS, Hong TH, You YK, Lee MA.

J Cancer Res Clin Oncol. 2012 Oct;138(10):1625-30. Epub 2012 May 22.

PMID:
22614154
2.

A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study.

Nakai Y, Isayama H, Sasaki T, Sasahira N, Tsujino T, Toda N, Kogure H, Matsubara S, Ito Y, Togawa O, Arizumi T, Hirano K, Tada M, Omata M, Koike K.

Br J Cancer. 2012 Jun 5;106(12):1934-9. doi: 10.1038/bjc.2012.183. Epub 2012 May 3.

3.

Cancer statistics, 2012.

Siegel R, Naishadham D, Jemal A.

CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.

4.

Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.

Suhail MM, Wu W, Cao A, Mondalek FG, Fung KM, Shih PT, Fang YT, Woolley C, Young G, Lin HK.

BMC Complement Altern Med. 2011 Dec 15;11:129. doi: 10.1186/1472-6882-11-129.

5.

Acyl derivatives of boswellic acids as inhibitors of NF-κB and STATs.

Kumar A, Shah BA, Singh S, Hamid A, Singh SK, Sethi VK, Saxena AK, Singh J, Taneja SC.

Bioorg Med Chem Lett. 2012 Jan 1;22(1):431-5. doi: 10.1016/j.bmcl.2011.10.112. Epub 2011 Nov 9.

PMID:
22123322
6.

Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.

Park B, Prasad S, Yadav V, Sung B, Aggarwal BB.

PLoS One. 2011;6(10):e26943. doi: 10.1371/journal.pone.0026943. Epub 2011 Oct 31. Erratum in: PLoS One. 2012;7(8): doi/10.1371/annotation/d4645c95-739f-4175-b753-b6fe0ba6063c.

7.

Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells.

Lee YJ, Jeong HY, Kim YB, Lee YJ, Won SY, Shim JH, Cho MK, Nam HS, Lee SH.

Food Chem Toxicol. 2012 Feb;50(2):116-23. doi: 10.1016/j.fct.2011.10.035. Epub 2011 Oct 14.

PMID:
22019695
8.

Regulation of cellular growth, apoptosis, and Akt activity in human U251 glioma cells by a combination of cisplatin with CRM197.

Wang L, Wang P, Liu Y, Xue Y.

Anticancer Drugs. 2012 Jan;23(1):81-9. doi: 10.1097/CAD.0b013e32834b9b72.

PMID:
21934602
9.

Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression.

Park B, Sung B, Yadav VR, Cho SG, Liu M, Aggarwal BB.

Int J Cancer. 2011 Jul 1;129(1):23-33. doi: 10.1002/ijc.25966. Epub 2011 Mar 29.

10.

Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial.

Kirste S, Treier M, Wehrle SJ, Becker G, Abdel-Tawab M, Gerbeth K, Hug MJ, Lubrich B, Grosu AL, Momm F.

Cancer. 2011 Aug 15;117(16):3788-95. doi: 10.1002/cncr.25945. Epub 2011 Feb 1.

11.

Safety and toxicological evaluation of Aflapin: a novel Boswellia-derived anti-inflammatory product.

Krishnaraju AV, Sundararaju D, Vamsikrishna U, Suryachandra R, Machiraju G, Sengupta K, Trimurtulu G.

Toxicol Mech Methods. 2010 Nov;20(9):556-63. doi: 10.3109/15376516.2010.497978. Epub 2010 Sep 29.

PMID:
20874664
12.

Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.

Holtmeier W, Zeuzem S, Preiss J, Kruis W, Böhm S, Maaser C, Raedler A, Schmidt C, Schnitker J, Schwarz J, Zeitz M, Caspary W.

Inflamm Bowel Dis. 2011 Feb;17(2):573-82. doi: 10.1002/ibd.21345.

PMID:
20848527
13.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Büchler MW; European Study Group for Pancreatic Cancer..

JAMA. 2010 Sep 8;304(10):1073-81. doi: 10.1001/jama.2010.1275.

PMID:
20823433
14.

Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the Gruppo Oncologico Italia Meridionale.

Gebbia V, Maiello E, Giuliani F, Borsellino N, Arcara C, Colucci G.

Am J Clin Oncol. 2010 Oct;33(5):461-4. doi: 10.1097/COC.0b013e3181b4e3b0.

PMID:
20142727
15.

Safety and Toxicological Evaluation of a Novel, Standardized 3-O-Acetyl-11-keto-beta-Boswellic Acid (AKBA)-Enriched Boswellia serrata Extract (5-Loxin(R)).

Lalithakumari K, Krishnaraju AV, Sengupta K, Subbaraju GV, Chatterjee A.

Toxicol Mech Methods. 2006;16(4):199-226. doi: 10.1080/15376520600620232.

PMID:
20021046
16.

Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.

Estrada AC, Syrovets T, Pitterle K, Lunov O, Büchele B, Schimana-Pfeifer J, Schmidt T, Morad SA, Simmet T.

Mol Pharmacol. 2010 Mar;77(3):378-87. doi: 10.1124/mol.109.060475. Epub 2009 Dec 16.

17.

LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells.

Liu JJ, Duan RD.

Anticancer Res. 2009 Aug;29(8):2987-91.

18.

Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M.

Cancer Res. 2009 Jul 15;69(14):5893-900. doi: 10.1158/0008-5472.CAN-09-0755. Epub 2009 Jun 30.

19.

Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.

Frank MB, Yang Q, Osban J, Azzarello JT, Saban MR, Saban R, Ashley RA, Welter JC, Fung KM, Lin HK.

BMC Complement Altern Med. 2009 Mar 18;9:6. doi: 10.1186/1472-6882-9-6.

20.

Analysis of mortality rates for pancreatic cancer across the world.

Hariharan D, Saied A, Kocher HM.

HPB (Oxford). 2008;10(1):58-62. doi: 10.1080/13651820701883148.

Supplemental Content

Support Center